KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Applied Molecular Transport Inc. Stock and on which exchange is it traded?
The symbol for Applied Molecular Transport Inc. is AMTI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Applied Molecular Transport Inc. Stock?
Applied Molecular Transport Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Applied Molecular Transport Inc. Stock?
Applied Molecular Transport Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Applied Molecular Transport Inc. Stock.

What's the current price of Applied Molecular Transport Inc. Stock?
As of the end of day on the Mar 25, 2024, the price of an Applied Molecular Transport Inc. (AMTI) share was $0.263.

What is the 52-week high and low for Applied Molecular Transport Inc. Stock?
The 52-week high for Applied Molecular Transport Inc. Stock is $0.489 and the 52-week low is $0.135.

What is the market capitalization of Applied Molecular Transport Inc. Stock?
As of the Mar 25, 2024, the market capitalization of Applied Molecular Transport Inc. is 11.006M.

When is the next earnings date for Applied Molecular Transport Inc.?
The upcoming earnings date for Applied Molecular Transport Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Applied Molecular Transport Inc.

Applied Molecular Transport. Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammat... AMTI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT